Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine PK in Neonates with HIE During Therapeutic Hypothermia
NCT02529202Phase 1Completed
- Sponsor
- Seattle Children's
- Start
- Mar 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dexmedetomidine in hypoxic-ischemic encephalopathy (HIE), sponsored by Seattle Children's. Primary endpoints: Area Under the Curve, Clearance and 2 more. Started Mar 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT02529202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02529202.